相似文献
1
Dengue virus inhibits the production of type I interferon in primary human dendritic cells.
J Virol. 2010 May;84(9):4845-50. doi: 10.1128/JVI.02514-09. Epub 2010 Feb 17.
2
Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.
J Virol. 2010 Oct;84(19):9760-74. doi: 10.1128/JVI.01051-10. Epub 2010 Jul 21.
3
Innate immunity evasion by Dengue virus.
Viruses. 2012 Mar;4(3):397-413. doi: 10.3390/v4030397. Epub 2012 Mar 15.
4
Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells.
J Infect Dis. 2011 Jun 15;203(12):1763-74. doi: 10.1093/infdis/jir197.
5
Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
mBio. 2017 Aug 1;8(4):e00741-17. doi: 10.1128/mBio.00741-17.
6
Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine/chemokine expression in dendritic cells.
Arch Virol. 2021 Jun;166(6):1623-1632. doi: 10.1007/s00705-021-05017-x. Epub 2021 Mar 29.
7
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
J Virol. 2014 Jul;88(13):7276-85. doi: 10.1128/JVI.03827-13. Epub 2014 Apr 16.
8
Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.
Front Immunol. 2020 Dec 17;11:605087. doi: 10.3389/fimmu.2020.605087. eCollection 2020.
9
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.
J Virol. 2001 Apr;75(8):3501-8. doi: 10.1128/JVI.75.8.3501-3508.2001.
10
DENV inhibits type I IFN production in infected cells by cleaving human STING.
PLoS Pathog. 2012;8(10):e1002934. doi: 10.1371/journal.ppat.1002934. Epub 2012 Oct 4.
引用本文的文献
1
Transcriptomic analysis of DENV-2-infected human dermal fibroblasts identified potential mechanisms that suppressed ZIKV replication during sequential coinfection.
Virol J. 2025 May 22;22(1):154. doi: 10.1186/s12985-025-02769-9.
2
MCP-1 Reduction by L-SIGN Expression in Dengue Virus-Infected Liver Endothelial Cells.
Viruses. 2025 Feb 28;17(3):344. doi: 10.3390/v17030344.
3
Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles.
J Virol. 2025 Mar 18;99(3):e0196224. doi: 10.1128/jvi.01962-24. Epub 2025 Feb 4.
4
Immunologic Crosstalk and Host-Specific Immune Signature Associated with Dengue.
ACS Omega. 2024 Aug 20;9(36):37418-37429. doi: 10.1021/acsomega.4c02506. eCollection 2024 Sep 10.
5
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.
Nat Commun. 2024 Jan 9;15(1):382. doi: 10.1038/s41467-023-44330-8.
6
Severe dengue progression beyond enhancement.
Nat Immunol. 2023 Dec;24(12):1967-1969. doi: 10.1038/s41590-023-01680-1.
7
Secreted NS1 proteins of tick-borne encephalitis virus and West Nile virus block dendritic cell activation and effector functions.
Microbiol Spectr. 2023 Sep 14;11(5):e0219223. doi: 10.1128/spectrum.02192-23.
8
Interplay between RNA viruses and cGAS/STING axis in innate immunity.
Front Cell Infect Microbiol. 2023 Apr 3;13:1172739. doi: 10.3389/fcimb.2023.1172739. eCollection 2023.
9
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature.
Exp Biol Med (Maywood). 2022 Dec;247(24):2201-2212. doi: 10.1177/15353702231151241.
10
Immune-Mediated Pathogenesis in Dengue Virus Infection.
Viruses. 2022 Nov 21;14(11):2575. doi: 10.3390/v14112575.
本文引用的文献
1
Subversion of interferon by dengue virus.
Curr Top Microbiol Immunol. 2010;338:35-44. doi: 10.1007/978-3-642-02215-9_3.
2
Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation.
J Infect Dis. 2009 Oct 15;200(8):1261-70. doi: 10.1086/605847.
3
The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells.
J Virol. 2009 Jul;83(13):6849-62. doi: 10.1128/JVI.02323-08. Epub 2009 Apr 29.
4
NS5 of dengue virus mediates STAT2 binding and degradation.
J Virol. 2009 Jun;83(11):5408-18. doi: 10.1128/JVI.02188-08. Epub 2009 Mar 11.
5
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus.
Virology. 2009 Jan 20;383(2):207-15. doi: 10.1016/j.virol.2008.10.022. Epub 2008 Nov 17.
6
Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.
PLoS Pathog. 2008 Oct;4(10):e1000193. doi: 10.1371/journal.ppat.1000193. Epub 2008 Oct 31.
7
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus.
J Leukoc Biol. 2008 Oct;84(4):1028-38. doi: 10.1189/jlb.0208105. Epub 2008 Jul 23.
8
The influenza virus NS1 protein: inhibitor of innate and adaptive immunity.
Infect Disord Drug Targets. 2007 Dec;7(4):336-43. doi: 10.2174/187152607783018754.
9
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.
J Med Virol. 2008 Jan;80(1):134-46. doi: 10.1002/jmv.21051.
10
Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.
Clin Vaccine Immunol. 2007 Jun;14(6):756-66. doi: 10.1128/CVI.00052-07. Epub 2007 Apr 11.
Zotero 插件